HIV-HBV coinfection among South African patients receiving antiretroviral therapy

scientific article

HIV-HBV coinfection among South African patients receiving antiretroviral therapy is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.3851/IMP1494
P932PMC publication ID3001165
P698PubMed publication ID20516571

P50authorLynne McNamaraQ55070042
Mhairi MaskewQ56521913
Adrian M. Di BisceglieQ87445433
P2093author name stringCindy Firnhaber
Doreen Schulze
Anne Reyneke
P2860cites workThe evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patientsQ45732718
Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.Q54498258
Young peopleʼs sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household surveyQ59153647
Prevalence of hepatitis B virus infection among black children in SowetoQ34286212
The prevalence of hepatitis B co-infection in a South African urban government HIV clinicQ34432918
Progress towards the comprehensive control of hepatitis B in Africa: a view from South AfricaQ34442006
Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South AfricaQ34468872
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART programQ37161725
Geographic distribution of human immunodeficiency virus in South Africa.Q37331590
Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal womenQ38926501
Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, JohannesburgQ39187042
Preimmunization epidemiology of hepatitis B virus infection in South African childrenQ39508435
Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypesQ43570104
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B.Q44260228
Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.Q44441066
Occult hepatitis B in HIV-infected patientsQ44949253
Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infectionQ45156938
High risk of occult hepatitis B virus infection in HIV-positive patients from South AfricaQ45459144
P433issue3 Pt B
P921main subjectSouth AfricaQ258
anti-retroviral agentQ50430310
P304page(s)499-503
P577publication date2010-01-01
P1433published inAntiviral TherapyQ4775353
P1476titleHIV-HBV coinfection among South African patients receiving antiretroviral therapy
P478volume15

Reverse relations

cites work (P2860)
Q38553056Current treatment of hepatitis B virus infections
Q54988709HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.
Q38651617HBV infection in untreated HIV-infected adults in Maputo, Mozambique.
Q40187537HBV influence on Response to Antiretroviral Therapy in Horizontally HIV-HBV Coinfected Patient during Early Childhood
Q35183973HIV, Hepatitis B, and Hepatitis C in Zambia
Q92440856Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance
Q36293979Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in Malawi
Q34743962High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda
Q40083239Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial
Q35063655Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial
Q34982182Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya
Q38602272Seroprevalence of Hepatitis B and Delta viruses among HIV infected population attending Antiretroviral clinic in selected health facilities in Abuja Nigeria
Q92771949Seroprevalence of hepatitis B virus: Findings from a population-based household survey in KwaZulu-Natal, South Africa
Q37375386Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana